AZN Archives - Spark Newswire

1 minute read

Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration

Yesterday, 1:35 PM

All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration

AMGN

5 minute read

‘Airbnb Has Foundational Cracks’, Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft’s Nadella Criticizes Google’s Exclusive Content Deals: Today’s Top Stories

By Vandana Singh

Yesterday, 10:11 AM

Benzinga

AAPL

1 minute read

Why Cancer-Focused ALX Oncology Stock Gained Over 100% Today?

By Vandana Singh

Yesterday, 8:58 AM

ALX Oncology Holdings Inc (NASDAQ: ALXO) released prespecified interim Phase 2 data from its ASPEN-06 trial of evorpacept plus trastuzumab, Cyramza (ramucirumab) and paclitaxel for HER2-positive gastric/

ALXO

1 minute read

AstraZeneca Settles Heartburn Treatment Lawsuit For One Of Biggest Selling Drug

By Vandana Singh

Yesterday, 8:18 AM

AstraZeneca Plc (NASDAQ: AZN) has

AZN

1 minute read

Legal
News

AstraZeneca Announced Earlier, It Settled Nexium Liability Litigations; AstraZeneca To Make Payment Of $425M

By Charles Gross

Yesterday, 4:45 AM

AstraZeneca has entered into settlement agreements in the product liability litigations related to Nexium and Prilosec. The agreements effectively resolve the product liability claims that are currently pending in the

AZN

1 minute read

Medicare Drug Price Negotiation – What Court’s Decision Means for Americans

By Vandana Singh

October 2, 10:54 AM

A U.S. District Judge has upheld a pivotal initiative of President Joe Biden, giving the green light for Medicare to commence negotiations on prescription drug prices.

AZN

2 minute read

Dianthus’ Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand – Analyst

By Vandana Singh

September 28, 3:33 PM

Raymond James initiated coverage on Dianthus Therapeutics Inc (NASDAQ: DNTH), a recent reverse merger with the old Magenta Therapeutics.

AZN

1 minute read

Pharma Giants Shift Stance, Embrace Medicare Negotiations Amid Rising Drug Costs

By Vandana Singh

September 28, 10:19 AM

AstraZeneca Plc (NASDAQ: AZN), Bristol Myers Squibb & Co (NYSE: BMY), and Boehringer Ingelheim are willing to participate in the initial round of Medicare drug price negotiation

AZN